Skip to main content
logo
Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
63.00
+3.45 (5.79%)
Jun 18, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Pharmaceuticals
6.67B5.72B5.39B3.21B1.68B
Pharmaceuticals Growth
16.46%6.11%67.82%91.07%186.34%
Total
6.67B5.72B5.39B3.21B1.68B
Total Growth
16.46%6.11%67.82%91.07%186.34%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Chinese Mainland
5.78B5.05B4.81B2.84B1.52B
Chinese Mainland Growth
14.58%4.89%69.35%87.42%232.77%
Asia Pacific (Excluding Chinese Mainland)
116.01M236.86M193.99M178.97M57.29M
Asia Pacific (Excluding Chinese Mainland) Growth
-51.02%22.10%8.39%212.42%187.75%
North America
465.47M329.12M314.79M145.06M-
North America Growth
41.43%4.55%117.01%--
South America
27.58M10.62M19.14M--
South America Growth
159.58%-44.50%---
Europe
275.80M101.41M56.37M50.14M109.54M
Europe Growth
171.96%79.91%12.43%-54.23%-2.37%
Oceania
-325.00K---
Total
6.67B5.72B5.39B3.21B1.68B
Total Growth
16.46%6.11%67.82%91.07%186.34%